Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein

Journal of Lipid Research

Volumn 37, Issue 7, 1996, Pages 1591-1600

  Halvorsen, Bente ^a   Brude, Ingeborg ^a   Drevon, Christian A ^a   Nysom, Jette ^a   Ose, Leiv ^b   Christiansen, Erling N ^a   Nenseter, Marit S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

free radicals; homocystinuria; lipid peroxidation; mononuclear cells; oxidized LDL

Indexed keywords

AZO COMPOUND; COPPER ION; FREE RADICAL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL FREE SYSTEM; HOMOCYSTINURIA; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MONONUCLEAR CELL; OXIDATION; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AMIDINES; ARTERIOSCLEROSIS; AZO COMPOUNDS; BEPRIDIL; CHILD; COPPER; FEMALE; FREE RADICAL SCAVENGERS; HOMOCYSTEINE; HOMOCYSTINURIA; HUMANS; LEUKOCYTES, MONONUCLEAR; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PICRATES;

EID: 0029891753     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Harker, L. A., S. J. Slichter, R. Scott, and R. Russell. 1974. Homocystinemia. Vascular injury and arterial thrombosis. N. Engl. J. Med. 291: 537-543.
2. Clarke, R., L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, and I. Graham. 1991. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 324: 1149-1155.
3. Malinow, M. R., G. Sexton, M. Averbuch, M. Grossman, D. Wilson, and B. Upson. 1990. Homocyst(e)inemia in daily practice: levels in coronary artery disease. Coronary Art. Dis. 1: 215-220.
4. Ueland, P. M., and H. Refsum. 1989. Plasma homocysteine, a risk factor for vascular disease: plasma levels in healthy, disease and drug therapy. J. Lab. Clin. Med. 114: 473-501.
5. Dudman, N. P. B., D. E. L. Wilcken, J. Wang, J. F. Lynch, D. Macey, and P. Lundberg. 1993. Disordered methionine/homocysteine metabolism in premature vascular disease. Arterioscler. Thromb. 13: 1253-1260.
6. Jocelyn, P. C. 1972. Biochemistry of the SH Group: The Occurrance, Chemical Properties, Metabolism and Biological Function of Thiols and Disulphides. Academic Press, Inc., New York. 84-115.
7. Witztum, J. L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
8. Steinberg, D., S. Parthasarathy, T. E. Carew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
9. Parthasarathy, S. 1987. Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim. Biophys. Acta. 917: 337-340.
10. Heinecke, J. W., M. Kawamura, L. A. Suzuki, and A. Chait. 1993. Oxidation of low density lipoprotein by thiols: superoxide-dependent and -independent mechanisms. J. Lipid Res. 34: 2051-2061.
11. Hirano, K., T. Ogihara, M. Miki, H. Yasuda, H. Tamai, N. Kawamura, and M. Mino. 1994. Homocysteine induces iron-catalyzed lipid peroxidation of low density lipoprotein that is prevented by alpha-tocopherol. Free Rad. Res. 21: 267-276.
12. Blom, H. J., D. P. E. Engelen, G. H. J. Boers, A. M. Stadhouders, R. C. A. Sengers, R. de Abreu, M. T. W. B. Tepoele-Pothoff, and J. M. F. Trijbels. 1992. Lipid peroxidation in homocysteinaemia. J. Inherit. Metab. Dis. 15: 419-422.
13. Dudman, N. P., D. E. Wilcken, and R. Stocker. 1993. Circulating lipid hydroperoxide levels in human hyperhomocysteinemia. Relevance to development of arteriosclerosis. Arterioscler. Thromb. 13: 512-516.
14. Dudman, N. P., and D. E. Wilcken. 1982. Homocysteine thiolactone and experimental homocysteinemia. Biochem. Med. 27: 244-253.
15. Havel, R. J., H. A. Eder, and H. F. Bradgon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1352.
16. Nenseter, M. S., B. Halvorsen, Ø. Rosvold, A. C. Rustan, and C. A. Drevon. 1995. Paracetamol inhibits copper ion-induced, azo compound-initiated, and mononuclear cell-mediated oxidative modification of LDL. Arterioscler. Thromb. Vasc. Biol. 15: 1338-1344.
17. Esterbauer, H., G. Striegl, H. Puhl, and M. Rotheneder. 1989. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Commun. 6: 67-75.
18. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52: 302-310.
19. Stocker, R., V. W. Bowry, and B. Frei. 1991. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl. Acad. Sci. USA. 8: 1646-1650.
20. Frei, B., and J. M. Gaziano. 1993. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J. Lipid Res. 34: 2135-2145.
21. Wallin, B., B. Rosengren, H. G. Shertzer, and G. Camejo. 1993. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for evaluation of antioxidants. Anal. Biochem. 208: 10-15.
22. Noble, R. P. 1968. Electrophoretic separation of plasma lipoproteins in agarose gel. J. Lipid Res. 9: 693-700.
23. Andersen, W. L., and D. B. Wetlaufer. 1975. A new method for disulfide analysis of peptides. Anal. Biochem. 67: 493-502.
24. Sparrow, C. P., and J. Olszewski. 1993. Cellular oxidation of low density lipoprotein is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34: 1219-1228.
25. Winterbourn, C. C. 1985. Comparative reactivities of various biological compounds with myeloperoxidase-hydrogen peroxide-chloride, and similarity of the oxidant to hypochlorite. Biochim. Biophys. Acta. 840: 204-210.
26. Malterud, K. M., T. L. Farbrot, A. E. Huse, and R. Bredo Sund. 1993. Antioxidant and radical scavenging effects of anthraquinones and anthrones. Pharmacology. 47: 77-85.
27. Refsum, H., P. M. Ueland, and A. M. Svardal. 1989. Fully automated fluorescence assay for determining total homocysteine in plasma. Clin. Chem. 35: 1921-1927.
28. Fiskerstrand, T., H. Refsum, G. Kvalheim, and P. M. Ueland. 1993. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin.Chem. 39: 263-271.
29. Starkenbaum, G., and J. M. Harlan. 1986. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77: 1370-1376.
30. Jones, B. G., F. A. Rose, and N. Tudball. 1994. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis. 105: 165-170.
31. Philis-Tsimikas, A., S. Parthasarathy, S. Picard, W. Palinski, and J. L. Witztum. 1995. Aminoguanidine has both pro-oxidant and antioxidant activity toward LDL. Arterioscler. Thromb. Vasc. Biol. 15: 367-376.
32. Heinecke, J. W., H. Rosen, L. A. Suzuki, and A. Chait. 1987. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 21: 10098-10103.
33. Satanam, N., and S. Parthasarathy. 1995. Cellular cysteine generation does not contribute to the initiation of LDL oxidation. J. Lipid Res. 36: 2203-2211.
34. Blom, H. J., H. A. Kleinveld, G. H. J. Boers, P. N. M. Demacker, H. L. M. Hak-Lemmers, M. T. W. B. Te Poele-Pothoff, and J. M. F. Trijbels. 1995. Lipid peroxidation and susceptibility of low density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur. J. Clin. Invest. 25: 149-154.
35. Tsai, J. C., M. A. Perella, M. Yoshizumi, C. M. Hsieh, E. Haber, R. Schlegel, and M. E. Lee. 1994. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA. 91: 6369-6373.
36. Watanabe, M., J. Osada, Y. Aratani, K. Kluckman, R. Reddick, M. R. Malinow, and N. Maeda. 1995. Mice deficient in cystathionine β-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA. 92: 1585-1589.